Skip to content

Author

N. Rekhtman

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Grade 3 Lung Carcinoids/NETs: The IASLC Pathology Committee Study with Proposal of a New Diagnostic Category.

INTRODUCTION Lung carcinoids are well-differentiated neuroendocrine tumors (NETs), designated in the current thoracic WHO classification as typical carcinoids (grade 1) and atypical carcinoids (grade 2), whereas rare tumors with carcinoid/NET morphology and >10 mitoses/2mm2 are designated as large cell neuroendocrine c...

N. Rekhtman, Matthew G. Hanna, Paul Hofman et al. · 0 citations
Open access Sep 2026

Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer

It is shown that P-selectin is expressed by a subset of senescent-like cells in fibrotic tissues and tumors, which establishes SMNPs as a generalizable strategy to target pathogenic senescent cell subsets across fibrosis and cancer.

Clemens Hinterleitner, Valentin J. A. Barthet, Hailey V. Goldberg et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.